Drugs in Dev.
Obstetrics/Gynecology (Women’s Health)
Phase III
Ireland 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Estradiol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Estradiol is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Atrophic Vaginitis.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
September 27, 2017
Lead Product(s) : Estradiol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
